This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Valeant Is Having a Healthy Run

Stocks in this article: CSCOPFELLYMRKVRXBMY

NEW YORK ( TheStreet) -- When an investor comes to me, I can tell where that person is in the Cycle of Disappointment.

First is the investor fresh from one of the big wire houses whose portfolios are full of well-known stocks that ran out of gas years ago.I'm thinking of stocks like Cisco (CSCO) and Pfizer (PFE) and Lilly (LLY).

Maybe there are a lot of bonds in there, too. That potential client did everything right, but still the returns were all wrong. The S&P 500 was up nearly 30% over the past year. Old stocks and old theories don't work, and some of these investors are just barely ahead for 2013.

Second is the do-it-yourselfer. After seeing the guys in suits underperform the market, this investor figures "how hard could it be?" and starts laying his own money down.

There is a lot of trading for a lot of the wrong reasons. I see lots of imbalances, maybe too much money in one stock, and people who underestimate the time and energy it takes to keep an eye on the market.

When I talk with them we discuss how markets have sectors, and how we should look for good stocks inside of hot sectors. This year, pharmaceuticals and biotechs have been hot.

As I checked out a potential client's portfolio the other day, I saw a few pharmaceutical companies including Pfizer, Lilly and Merck (MRK). But are these the pharmas to hold in the future? Not really.

Last year was good to the pharmaceuticals. In fact, pharma is now my third-ranked sector in the market.

Data from Best Stocks Now App

One stock that gets high marks from my Best Stocks Now app is Valeant Pharmaceuticals (VRX).

Data from Best Stocks Now App

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,677.90 +216.58 1.32%
S&P 500 1,950.82 +23.71 1.23%
NASDAQ 4,452.7920 +69.9450 1.60%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs